NTRA:NASDAQ
Natera Inc
$395.56
arrow_downward
-1.27%(-5.09) 1D
$390.00
arrow_downward
-1.41% (-5.56)todayPre-market
Closed: Oct 7, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NTRA...
Open
$393.02
High
$401.09
Low
$383.45
Mkt. cap
57.02B
Avg. vol.
1.56M
Volume
1.48K
52-wk high
$437.41
52-wk low
$167.98
EPS
-$1.37
Beta
1.50
Shares outstanding
144.14M
No. of employees
6K
Open
$393.02
High
$401.09
Low
$383.45
Mkt. cap
57.02B
Avg. vol.
1.56M
Volume
1.48K
52-wk high
$437.41
52-wk low
$167.98
EPS
-$1.37
Beta
1.50
Shares outstanding
144.14M
No. of employees
6K
News stories
From web sources and news partners
AD HOC NEWS
·
20 hours ago
Natera stock trades at USD 396.98 as clinical trials expand
AD HOC NEWS
·
22 hours ago
Natera launches melanoma trial as Citi lifts Natera stock target to USD 480.00
Traders Union
·
1 day ago
Natera stock falls nearly 6% as sellers override momentum despite strong phase III trial news
TradingKey
·
1 day ago
Natera Inc Stock (NTRA) Moved Down by 5.30% on Oct 6: A Full Analysis
Profile
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
About Natera Inc
CEOSteven Chapman
Employees6.14K
FoundedJan 1, 2004
HeadquartersAustin, Texas, United States
SectorBiotechnology
Websitenatera.com